Coen Maas

Title: Coen Maas: Innovator in Medical Science

Introduction

Coen Maas is a prominent inventor based in Utrecht, Netherlands. He has made significant contributions to the field of medical science, particularly in the development of innovative therapies for thrombolysis and bradykinin-mediated diseases. With a total of 2 patents, his work is paving the way for advancements in targeted treatments.

Latest Patents

Maas's latest patents include "Fusion Protein for Targeted Thrombolysis for Treatment of Microvascular Thrombosis" and "Modified Serpins for the Treatment of Bradykinin-Mediated Disease." The latter invention focuses on modified serine protease inhibitors (serpins) that have mutations in their reactive center loop. These modifications enhance the serpin's ability to inhibit plasma kallikrein while ensuring minimal inhibition of thrombin and activated protein C. The invention also includes nucleic acid molecules encoding these modified serpins, which can be utilized in gene therapy vectors and pharmaceutical compositions.

Career Highlights

Throughout his career, Coen Maas has worked with notable organizations such as Preclinics Gesellschaft für Präklinische Forschung mbH and UMC Utrecht Holding B.V. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Steven De Maat, with whom he has worked on various projects aimed at enhancing therapeutic options in medical science.

Conclusion

Coen Maas is a distinguished inventor whose work in medical innovations is making a significant impact. His patents reflect a commitment to advancing treatment options for complex medical conditions.